• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The venous occlusion test in assessing the fibrinolytic activity of the vascular endothelium in lupus nephritis patients].

作者信息

Bobkova I N, Poliantseva L R, Tareeva I E, Andreenko G V, Podorol'skaia L V

出版信息

Ter Arkh. 1995;67(4):42-5.

PMID:7784974
Abstract

A venous occlusion test was used to evaluate the reserves of the kidneys and that of vascular endothelium fibrinolytic activity (VEFA) in patients with lupus nephritis (LN). Prior to and following venous occlusion functional activity of plasminogen activators in plasma and urine (PAPU), plasma activity of antiactivator (PAAA), urokinase urine activity (UUA) were measured by fibrin plate lysis test in 24 patients with active LN, 6 SLE patients with intact kidneys, 10 healthy subjects. Venous occlusion test revealed normal reserve of plasma activator activity in mild LN and depletion of this reserve in LN patients with nephrotic syndrome and rapidly progressive LN. In the latter patients PAPU and PAAA were suppressed. PAPU reserve existed in all the patients, but those with rapidly progressive LN. UUA in LN was close to normal and did not change significantly after venous occlusion. The data obtained suggest that patients with severe LN had reduced reserves of VEFA, while in those with progressive LN there were also diminished reserves of renal fibrinolytic activity reflecting the severity of endothelial lesion.

摘要

相似文献

1
[The venous occlusion test in assessing the fibrinolytic activity of the vascular endothelium in lupus nephritis patients].
Ter Arkh. 1995;67(4):42-5.
2
[The functional activity of plasminogen activators in the blood plasma and urine of patients with lupus nephritis].[狼疮性肾炎患者血浆和尿液中纤溶酶原激活剂的功能活性]
Ter Arkh. 1994;66(6):39-41.
3
[Tissue-type plasminogen activator in patients with lupus nephritis].
Ter Arkh. 1995;67(5):17-9.
4
[The clinical importance of determining the von Willebrand factor in patients with lupus nephritis].[测定狼疮性肾炎患者血管性血友病因子的临床意义]
Ter Arkh. 1995;67(5):14-6.
5
[Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].[尿内皮功能障碍标志物及血管生成因子检测在慢性肾小球肾炎肾小管间质纤维化评估中的临床意义]
Ter Arkh. 2007;79(6):10-5.
6
[The criteria for indication of plasma exchange on lupus nephritis].
Nihon Jinzo Gakkai Shi. 1990 Jun;32(6):703-13.
7
[Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].[内皮功能障碍和血液流变学紊乱标志物对评估慢性肾小球肾炎活动度和预后的意义]
Ter Arkh. 2010;82(1):47-51.
8
[Urinary fibronectin as an indicator of kidney fibrosis in nephritis].[尿纤连蛋白作为肾炎肾纤维化的指标]
Ter Arkh. 1999;71(6):34-8.
9
[Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
Pol Tyg Lek. 1993;48(5-6):116-9.
10
The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.经活检证实的中国患者狼疮性肾炎的预后:86例长期随访
Chin Med J (Engl). 1997 Jul;110(7):502-7.